Cargando…

Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study

BACKGROUND: Influenza vaccine policies that maximise health benefit through efficient use of limited resources are needed. Generally, influenza vaccination programmes have targeted individuals 65 y and over and those at risk, according to World Health Organization recommendations. We developed metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Baguelin, Marc, Flasche, Stefan, Camacho, Anton, Demiris, Nikolaos, Miller, Elizabeth, Edmunds, W. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793005/
https://www.ncbi.nlm.nih.gov/pubmed/24115913
http://dx.doi.org/10.1371/journal.pmed.1001527
_version_ 1782286919581827072
author Baguelin, Marc
Flasche, Stefan
Camacho, Anton
Demiris, Nikolaos
Miller, Elizabeth
Edmunds, W. John
author_facet Baguelin, Marc
Flasche, Stefan
Camacho, Anton
Demiris, Nikolaos
Miller, Elizabeth
Edmunds, W. John
author_sort Baguelin, Marc
collection PubMed
description BACKGROUND: Influenza vaccine policies that maximise health benefit through efficient use of limited resources are needed. Generally, influenza vaccination programmes have targeted individuals 65 y and over and those at risk, according to World Health Organization recommendations. We developed methods to synthesise the multiplicity of surveillance datasets in order to evaluate how changing target populations in the seasonal vaccination programme would affect infection rate and mortality. METHODS AND FINDINGS: Using a contemporary evidence-synthesis approach, we use virological, clinical, epidemiological, and behavioural data to develop an age- and risk-stratified transmission model that reproduces the strain-specific behaviour of influenza over 14 seasons in England and Wales, having accounted for the vaccination uptake over this period. We estimate the reduction in infections and deaths achieved by the historical programme compared with no vaccination, and the reduction had different policies been in place over the period. We find that the current programme has averted 0.39 (95% credible interval 0.34–0.45) infections per dose of vaccine and 1.74 (1.16–3.02) deaths per 1,000 doses. Targeting transmitters by extending the current programme to 5–16-y-old children would increase the efficiency of the total programme, resulting in an overall reduction of 0.70 (0.52–0.81) infections per dose and 1.95 (1.28–3.39) deaths per 1,000 doses. In comparison, choosing the next group most at risk (50–64-y-olds) would prevent only 0.43 (0.35–0.52) infections per dose and 1.77 (1.15–3.14) deaths per 1,000 doses. CONCLUSIONS: This study proposes a framework to integrate influenza surveillance data into transmission models. Application to data from England and Wales confirms the role of children as key infection spreaders. The most efficient use of vaccine to reduce overall influenza morbidity and mortality is thus to target children in addition to older adults. Please see later in the article for the Editors' Summary
format Online
Article
Text
id pubmed-3793005
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37930052013-10-10 Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study Baguelin, Marc Flasche, Stefan Camacho, Anton Demiris, Nikolaos Miller, Elizabeth Edmunds, W. John PLoS Med Research Article BACKGROUND: Influenza vaccine policies that maximise health benefit through efficient use of limited resources are needed. Generally, influenza vaccination programmes have targeted individuals 65 y and over and those at risk, according to World Health Organization recommendations. We developed methods to synthesise the multiplicity of surveillance datasets in order to evaluate how changing target populations in the seasonal vaccination programme would affect infection rate and mortality. METHODS AND FINDINGS: Using a contemporary evidence-synthesis approach, we use virological, clinical, epidemiological, and behavioural data to develop an age- and risk-stratified transmission model that reproduces the strain-specific behaviour of influenza over 14 seasons in England and Wales, having accounted for the vaccination uptake over this period. We estimate the reduction in infections and deaths achieved by the historical programme compared with no vaccination, and the reduction had different policies been in place over the period. We find that the current programme has averted 0.39 (95% credible interval 0.34–0.45) infections per dose of vaccine and 1.74 (1.16–3.02) deaths per 1,000 doses. Targeting transmitters by extending the current programme to 5–16-y-old children would increase the efficiency of the total programme, resulting in an overall reduction of 0.70 (0.52–0.81) infections per dose and 1.95 (1.28–3.39) deaths per 1,000 doses. In comparison, choosing the next group most at risk (50–64-y-olds) would prevent only 0.43 (0.35–0.52) infections per dose and 1.77 (1.15–3.14) deaths per 1,000 doses. CONCLUSIONS: This study proposes a framework to integrate influenza surveillance data into transmission models. Application to data from England and Wales confirms the role of children as key infection spreaders. The most efficient use of vaccine to reduce overall influenza morbidity and mortality is thus to target children in addition to older adults. Please see later in the article for the Editors' Summary Public Library of Science 2013-10-08 /pmc/articles/PMC3793005/ /pubmed/24115913 http://dx.doi.org/10.1371/journal.pmed.1001527 Text en © 2013 Baguelin et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Baguelin, Marc
Flasche, Stefan
Camacho, Anton
Demiris, Nikolaos
Miller, Elizabeth
Edmunds, W. John
Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study
title Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study
title_full Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study
title_fullStr Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study
title_full_unstemmed Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study
title_short Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study
title_sort assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793005/
https://www.ncbi.nlm.nih.gov/pubmed/24115913
http://dx.doi.org/10.1371/journal.pmed.1001527
work_keys_str_mv AT baguelinmarc assessingoptimaltargetpopulationsforinfluenzavaccinationprogrammesanevidencesynthesisandmodellingstudy
AT flaschestefan assessingoptimaltargetpopulationsforinfluenzavaccinationprogrammesanevidencesynthesisandmodellingstudy
AT camachoanton assessingoptimaltargetpopulationsforinfluenzavaccinationprogrammesanevidencesynthesisandmodellingstudy
AT demirisnikolaos assessingoptimaltargetpopulationsforinfluenzavaccinationprogrammesanevidencesynthesisandmodellingstudy
AT millerelizabeth assessingoptimaltargetpopulationsforinfluenzavaccinationprogrammesanevidencesynthesisandmodellingstudy
AT edmundswjohn assessingoptimaltargetpopulationsforinfluenzavaccinationprogrammesanevidencesynthesisandmodellingstudy